Bringing Ayahuasca to the Clinical Research Laboratory

This commentary article (2005) describes the clinical trials involving the administration of ayahuasca to healthy volunteers at the Autonomous University of Barcelona.

Abstract of Bringing Ayahuasca to the Clinical Research Laboratory

“Since the winter of 1999, the authors and their research team have been conducting clinical studies involving the administration of ayahuasca to healthy volunteers. The rationale for conducting this kind of research is twofold. First, the growing interest of many individuals for traditional indigenous practices involving the ingestion of natural psychotropic drugs such as ayahuasca demands the systematic study of their pharmacological profiles in the target species, i.e., human beings. The complex nature of ayahuasca brews combining a large number of pharmacologically active compounds requires that research be carried out to establish the safety and overall pharmacological profile of these products. Second, the authors believe that the study of psychedelics in general calls for renewed attention. Although the molecular and electrophysiological level effects of these drugs are relatively well characterized, current knowledge of the mechanisms by which these compounds modify the higher order cognitive processes in the way they do is still incomplete, to say the least. The present article describes the development of the research effort carried out at the Autonomous University of Barcelona, commenting on several methodological aspects and reviewing the basic clinical findings. It also describes the research currently underway in our laboratory, and briefly comments on two new studies we plan to undertake in order to further our knowledge of the pharmacology of ayahuasca.”

Authors: Jordi Riba & Manel J. Barbanoj

Summary of Bringing Ayahuasca to the Clinical Research Laboratory

In 1994, the authors had the unusual opportunity of directly witnessing the arrival of a religious tradition in Spain that involved the use of ayahuasca, a psychotropic plant concoction. Participants would sit in rows of chairs, separated by sex, and remain in a kind of slumber for most of the session.

Participants would drink tea and lie down for several hours, then discuss the effects with experienced participants.

The fact that ayahuasca use did not appear to interfere with daily life made this pattern of psychotropic drug use a remarkable social phenomenon. It was also suggested that ayahuasca might be amenable to study in a clinical research setting.

To access this content, you must purchase one of the following memberships: Sprout Membership, Pro Membership, Pro Membership Unlimited, Business Membership or Business Membership Unlimited. The membership will give you access to exclusive data, including summaries of psychedelic research papers, extended company info, and our member-only visualisations. Save yourself multiple hours each week by accessing Blossom’s resource library.

Find this paper

Bringing Ayahuasca to the Clinical Research Laboratory

https://doi.org/10.1080/02791072.2005.10399804

Open Access | Google Scholar | Backup | 🕊

Cite this paper (APA)

Riba, J., & Barbanoj, M. J. (2005). Bringing ayahuasca to the clinical research laboratory. Journal of psychoactive drugs37(2), 219-230.

Study details

Compounds studied
Ayahuasca

Topics studied
Safety

Study characteristics
Commentary

PDF of Bringing Ayahuasca to the Clinical Research Laboratory